In HCS Pharma we strongly believe that 3D is the right way to improve drugs dicovery processes. It’s why we develop our 3D hydroscaffold matrix BIOMIMESYS® for 3D cell culture and we invest in 3D pictures acquisition (and analyse) with our partner Molecular Devices.

Then we are very please to be present at SLAS 2018 “Advanced 3D Human Models and High-Content Analysis Conference“, 17-19 October 2018 in Leiden (Netherlands). We will present BIOMIMESYS® technology of course but also our HCS models in oncology and neurology. 

If you will be in Leiden or if you want to talk about these models, feel free to contact us.

.


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

Leave a Reply